Ofev 150 MG capsule 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F88HJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,053
Award facts
- Contract value 100% obligated
- $9,053.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $9,053.16 delivery order to AmerisourceBergen Drug Corp for OFEV 150 mg capsules (60-count) with a firm fixed price arrangement. This contract, issued on December 22, 2025, with an ultimate completion date of January 14, 2026, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made on a competitive basis without any set-aside designation, and performance will occur at the contractor's Conshohocken, Pennsylvania location. OFEV (nintedanib) is an antifibrotic medication used in treating pulmonary fibrosis and other progressive fibrosing interstitial lung diseases, reflecting the pharmaceutical distributor's critical role in supplying specialty medications to federal healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, holds a $999,999,999.00 prime IDC with DLA Troop Support Medical (designated SPE2DX) that extends through December 2026. This comprehensive vehicle enables the company to supply a broad portfolio of pharmaceutical products and medical supplies to support military healthcare programs globally, including serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's demonstrated capability to fulfill federal procurement requirements through competitive awards, combined with its extensive experience in delivering specialty medications and medical commodities across multiple therapeutic domains, positions it as a significant vendor within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F88HJ?
SPE2DR26F88HJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26F88HJ worth?
The government has obligated $9,053 on SPE2DR26F88HJ.
Is contract SPE2DR26F88HJ an order under another contract?
Yes. SPE2DR26F88HJ is a delivery order under SPE2DR25D3010, an indefinite delivery contract.
Was contract SPE2DR26F88HJ competed?
The extent of competition for SPE2DR26F88HJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award